Successful medical treatment of Acanthamoeba keratitis

International Ophthalmology

Volumn 21, Issue 4, 1997, Pages 223-227

  Azuara Blanco, Augusto ^a   Sadiq, Ahmed S ^a   Hussain, M ^a   Lloyd, John H ^a   Dua, Harminder S ^a  

^a QUEEN S MEDICAL CENTRE   (United Kingdom)

Author keywords

Acanthamoeba; Keratitis; Polyhexamethylene biguanide; Propamidine

Indexed keywords

ANTIBIOTIC AGENT; BACITRACIN ZINC; POLY(HEXAMETHYLENEBIGUANIDE); POLYFAX; POLYMYXIN B; PREDNISOLONE ACETATE; PROPAMIDINE ISETHIONATE; STEROID; UNCLASSIFIED DRUG;

ACANTHAMOEBA; ADULT; ARTICLE; CLINICAL ARTICLE; CONTACT LENS; FEMALE; HUMAN; IRIDOCYCLITIS; KERATITIS; MALE; PAIN; RETROSPECTIVE STUDY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ADMINISTRATION, TOPICAL; ADULT; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIPROTOZOAL AGENTS; BENZAMIDINES; BIGUANIDES; CONTACT LENSES, HYDROPHILIC; CORNEA; DISINFECTANTS; DISPOSABLE EQUIPMENT; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; KERATOPLASTY, PENETRATING; MALE; OPHTHALMIC SOLUTIONS; VISUAL ACUITY;

EID: 0031401111     PISSN: 01655701     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006055918101     Document Type: Article

References (17)

1. Stehr-Green JK, Bailey TM, Visvesvera GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol 1989; 107: 331-6.
2. Moore MB, McCulley JP, Newton C, Cobo LM, Foulks GN, O'Day DM et al. Acanthamoeba keratisis - a growing problem in soft and hard contact lens wearers. Ophthalmology 1987; 94: 1654-61.
3. Matthers WD, Stuphin JE, Folberg R, Meier PA, Wenzel RP, Elgin RG. Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 1996; 121: 129-42.
4. Illingworth CD, Cook SD, Karabatsas CH, Easty DL. Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 1995; 79: 1078-82.
5. Auran JD, Starr MB, Jakobiec FA. Acanthamoeba keratitis: a review of the literature. Cornea 1987; 6: 2-26.
6. Larkin DFP, Kilvington S, Dart JKG. Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 1992; 99: 185.
7. Hay J, Kirkness CM, Seal DV, Wright P. Drug resistance and Acanthamoeba keratitis: The quest for alternative protozoal chemotherapy. Eye 1994; 8: 555-63.
8. Elder MJ, Dart JKG. Chemotherapy for Acanthamoeba keratitis. Lancet 1995; 345: 791-2.
9. Varga JH, Wolf TC, Jensen HG, Parmley VG, Rowsey JJ.
10. Berget ST, Mondino BJ, Hoft RH et al. Successful medical management of Acanthamoeba keratitis. Am J Ophthalmol 1990; 395-403.
11. Ficker L, Seal DV, Warhurst D, Wright P. Acanthamoeba keratitis: resistance to medical therapy. Eye 1990; 4: 835-8.
12. Seal DV, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, Ridgway A, Armstrong M. Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 1996; 10: 413-21.
13. Cohen JJ, Parlato CJ, Arentsen JJ et al. Medical and surgical treatment of Acanthamoeba keratitis. Am J Ophthalmol 1987; 103: 615-25.
14. D'Anverse G, Stern GA, Driebe WT Jr. Diagnosis and sucessful medical treatment of Acanthamoeba keratitis. Arch Ophthalmol 113(9): 1120-3, 1995 Sep.
15. Lindquist TK, Shev NA, Doughman DJ. Clinical signs and medical therapy of early Acanthamoeba keratitis. Arch Ophthalmol 1988; 106: 73-7.
16. Seal DV, Hay J, Kirkness CM. Chlorhexidine or polyhexamethylene biguinide for acanthamoeba keratitis. Lancet 1995; 345: 136.
17. Elder MJ, Kilvington S, Dart JKG. A clinicopathologic study of in vitro sensitivity testig and Acanthamoeba keratitis. Invest Ophthalmol Vis Sci 1994; 35: 1059-64.